B+
Bull case
25%
Probability
Target price
$5.38
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
SRTS
Sensus HealthcareBNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
55%
Probability
Target price
$3.85
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$2.10
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-09-03
Recent news sentiment (30D)
+0.6
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+93.3
Score
AI commentary
Recent company-reported news is moderately positive on CPT implementation, pipeline activity and reimbursement potential, but the Q2 revenue decline materially tempers the tone. The packet does not provide a verified post-release price reaction, analyst revisions or target changes; missing revision data is not treated as positive evidence. Social coverage was unavailable.
RankAlpha Sentiment Codex - 2026-09-03
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-12-02eventPotential reimbursement improvementHigh impact
CMS proposed a 26% increase in the hospital-based SRT delivery code. If finalized, this could improve provider economics and support hospital and health-system adoption, but the proposal remains unfinalized. [#SEC-8K-2026-08-13]
2026-12-02catalystQ3 recognition of eight sold unitsHigh impact
Q2 revenue was depressed because financing approval timing prevented recognition of eight units; the SEC-reported update states approvals were subsequently completed and related revenue is expected in Q3. This is primarily a timing recovery, not confirmed incremental demand. [#SEC-8K-2026-08-13]
2027-09-03catalystCPT-driven adoption and commercial expansionHigh impact
Dedicated CPT codes became effective in 2026, while management reported stronger pipeline activity, broader engagement across practices, physician groups and health systems, and expanding Asia-Pacific activity. Execution has not yet translated into sustained revenue growth. [#SEC-8K-2026-08-13]
Recommendation
N/A
No formal recommendation provided.
As of 2026-09-03 • Updated nightlySource: Internal modelMethodology